Ovary Part 4
This is the fourth of seven episodes covering ovarian cancer. In this episode, we discuss the management of recurrent, platinum-resistant epithelial ovarian cancer. Join us to explore the prognosis of PROC, recommendations for systemic chemotherapy, the role of bevacizumab, the updates to FDA approval for PARPi use, and options for targeted therapies.
Uterine Cancer: Part 4
In our fourth episode on uterine cancer, we discuss uterine carcinosarcoma as the last subtype of endometrial cancer. We then discuss uterine sarcomas, including nuances of staging and treatment of different subtypes of uterine sarcoma in both the up-front and recurrent setting.